Benzinga's Top Ratings Upgrades, Downgrades For June 28, 2022
Upgrades
Benzinga ·
Get all your news in one place.
100's of premium titles.
One app.
Start reading
One app.
Get all your news in one place.
100's of premium titles. One news app.
HISTORICAL FACTS: Cogent biosciences | History Defined
Why Shares Of Cogent Biosciences Are Trading Higher
Cogent Biosciences, Inc. (NASDAQ: COGT) shares are trading higher after the company reported initial data from its ongoing Phase 2 APEX clinical trial.
Benzinga ·
From analysis to the latest developments in health,
read the most diverse news in one place.
read the most diverse news in one place.
Coverage From
Benzinga
Organisations
Nasdaq
22,823 stories
NYSE
19,907 stories
Goldman Sachs
2,772 stories
eBay
2,301 stories
UBS
1,077 stories
JP Morgan
755 stories
Novo Nordisk
743 stories
Jefferies
729 stories
Snowflake
393 stories
Polaris
320 stories
State Street
129 stories
FarFetch
128 stories
SoundHound AI
85 stories
Microchip Technology
79 stories
Zendesk
71 stories
Riot Blockchain
58 stories
Argus Research
52 stories
Banner
50 stories
Molson Coors Beverage
23 stories
Ovintiv
17 stories
From analysis to the latest developments in health,
read the most diverse news in one place.
read the most diverse news in one place.
Topics
Read news from The Economist, FT, and more,
with one subscription
with one subscription
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.
100+ trusted global sources.
